Survival of patients with head and neck cancer treated with definitive radiotherapy and concurrent cisplatin or concurrent cetuximab: A Surveillance, Epidemiology, and End Results ‐Medicare analysis

Cancer, EarlyView.

Source: Cancer - October 17, 2018 Category: Cancer & Oncology Authors: Michael Xiang, F. Christopher Holsinger, A. Dimitrios Colevas, Michelle M. Chen, Quynh ‐Thu Le, Beth M. Beadle Source Type: research